A new radiotheranostic system has the ability to detect and treat ovarian cancer noninvasively, according to new research published in the April issue of the Journal of Nuclear Medicine. Combining the highly specific huAR9.6 ...
Apr 3, 2024
0
2
The Princess of Wales released a moving video message on March 22 to address speculation about her health. In it, the future queen disclosed that she'd been diagnosed with cancer following tests conducted after she underwent ...
Mar 25, 2024
0
0
Patients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid extensive removal of the lymph nodes if their treatment is tailored to their response to cancer-killing therapies such ...
Mar 21, 2024
0
0
The results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer new hope to patients with metastatic and recurrent uterine cancer, also known as endometrial ...
Mar 20, 2024
0
0
Women with a type of ovarian cancer known as germ cell tumors have a worse prognosis than men with similar tumors (i.e., testicular cancer). After five years with the disease, 98% of men were alive while the survival rate ...
Mar 12, 2024
0
0
A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.
Mar 11, 2024
0
1
There are stark differences between European countries when it comes to both the reimbursement of, and access to, new treatments for patients with early-stage lung cancer. There are also differences in reimbursement times ...
Mar 4, 2024
0
0
A University of Cincinnati Cancer Center study has found that real-time navigation is a useful tool for surgeons performing ablation procedures to destroy tumors in the liver.
Feb 29, 2024
0
0
People in the UK have been treated with chemotherapy and radiotherapy less often than patients in comparable countries, and faced long waits for treatments, according to two new studies published in The Lancet Oncology.
Feb 26, 2024
0
0
A four-drug chemotherapy regimen of irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil—together referred to as NALIRIFOX—has been approved by the U.S. Food and Drug Administration ...
Feb 16, 2024
0
4
